1422 / 1851
4th cycle ABVD then IFRT
Randomisation
30 Gy IFRT
No further
treatment
PET +ve
(25.3%)
PET –ve
(74.7%)
UK NCRI RAPID trial
Initial treatment: 3 x ABVD
Re-assessment: if response, PET scan performed
N.B.
Favourable features
according with GHSG criteria were present in
74%
of
patients randomized to
“NFT”
(65.1% in patients randomized to 30 Gy IFRT)